Year: 2015
Type: review
Abstract: Adipocytes are not merely organs for energy conservation but endocrine organs secreting a wide array of physiologically active substances, i.e., adipokines. Of these adipokines, adiponectin is known to exert anti-diabetic and anti-atherosclerotic effects via adiponectin receptors (AdipoR)s, AdipoR1 and AdipoR2. Adiponectin has also recently been shown to regulate longevity signaling thus prolonging lifespan. Therefore, the strategy for activating adiponectin/AdipoR signaling pathways are expected to provide a solid basis for the prevention and treatment of obesity-related diseases such as the metabolic syndrome, type 2 diabetes and cardiovascular disease, as well as for ensuring healthy longevity in humans.
Institutions: Japan Science and Technology Agency, The University of Tokyo
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,090
Awards: Unraveling the mechanisms of exercise-mimicking adiponectin receptor signaling, Pathophysiological roles of adipokines in the regulation of gut microbiota in life-style related diseases, Building and establishing platform technologies for Structure Based Drug Design targeting AdipoR, Comprehensive and expansive research of the universal metabolic regulation mechanisms for healthspan
OpenAlex ID: W2255303216
